137 related articles for article (PubMed ID: 29545897)
41. [Effects of cytokines on multidrug-resistance in K562/A02 cells].
Liu L; Liu F; Yang C; Qi Y; Yang L; Qi J; Xu Y
Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):646-8. PubMed ID: 15625765
[TBL] [Abstract][Full Text] [Related]
42. [Effect of neferine combined with mdr-1shRNA on the expression of mdr-1/P-gp in K562/A02 cell line].
Qin Q; Xiao X; Xie Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):445-50. PubMed ID: 20543467
[TBL] [Abstract][Full Text] [Related]
43. Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts.
Ji M; Shi Y; Lou H
Biosci Trends; 2011; 5(5):192-7. PubMed ID: 22101374
[TBL] [Abstract][Full Text] [Related]
44. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
[TBL] [Abstract][Full Text] [Related]
45. [Effect of cyclosporine A, raloxifene and their combination on the reversion of multidrug resistance of K562/A02 line].
Bao W; Chen BA; Gao F; Ding JH; Xu WL; Sheng HL; Gao C; Sun YY; Chen J; Wang J; Zhao G; Ma Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):895-9. PubMed ID: 17096884
[TBL] [Abstract][Full Text] [Related]
46. [Study on the compound Fritilaria thunbergii Miq particles to the subcellular accumulation ability and inducing apoptosis of K562/A02 cells].
Zheng Z; Li DY; Chen XY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):167-9. PubMed ID: 20462045
[TBL] [Abstract][Full Text] [Related]
47. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
[TBL] [Abstract][Full Text] [Related]
48. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
Xiao XB; Xie ZX; Qin Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
[TBL] [Abstract][Full Text] [Related]
49. [Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells].
Gao N; Zhang Y; Mao JQ; Li GQ; Zhou W; Gao B; Gu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):785-9. PubMed ID: 18718061
[TBL] [Abstract][Full Text] [Related]
50. [Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].
Xu WL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Shen HL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):400-5. PubMed ID: 20017303
[TBL] [Abstract][Full Text] [Related]
51. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].
Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496
[TBL] [Abstract][Full Text] [Related]
52. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
[TBL] [Abstract][Full Text] [Related]
53. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.
Peng H; Yuan X; Shi R; Wei X; Ren S; Yan C; Ding Y; Lin Y; Fan D; Yang M; Zhang Y; Xiong D
Eur J Pharmacol; 2013 Oct; 718(1-3):459-68. PubMed ID: 23911883
[TBL] [Abstract][Full Text] [Related]
54. Assessment of Thiosemicarbazone-Containing Compounds as Potential Antileukemia Agents against P-gp Overexpressing Drug Resistant K562/A02 Cells.
Gu X; Guan M; Jiang C; Song Q; Li X; Sun N; Chen J; Qiu J
Chem Biodivers; 2021 Feb; 18(2):e2000775. PubMed ID: 33314614
[TBL] [Abstract][Full Text] [Related]
55. [Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].
Zhao QX; Chen BA; Cheng J; Ding JH; Gao F; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):61-4. PubMed ID: 18315901
[TBL] [Abstract][Full Text] [Related]
56. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
57. [Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
Wang ZX; Yang ZM; Zou YW; Li MM; Chen FX; Zhong GY; Guan JM; Wei FG; Wu SZ; He ZT; Wu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):19-23. PubMed ID: 21362214
[TBL] [Abstract][Full Text] [Related]
58. [Studies on reversing MDR of K562/A02 by ramification of curcumin hydrolyzed].
Huang Y; Dong G; Hong X; Chai H; Yuan X
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2460-3. PubMed ID: 21141501
[TBL] [Abstract][Full Text] [Related]
59. The Mechanism of Bufalin-Induced Apoptosis of K562/A02.
Xie Y; Yan X; Sun L
Med Sci Monit; 2019 Apr; 25():2542-2552. PubMed ID: 30955024
[TBL] [Abstract][Full Text] [Related]
60. Effects of griseofulvin on apoptosis through caspase-3- and caspase-9-dependent pathways in K562 leukemia cells: An in vitro study.
Zhong N; Chen H; Zhao Q; Wang H; Yu X; Eaves AM; Sheng W; Miao J; Cui F; Wang J
Curr Ther Res Clin Exp; 2010 Dec; 71(6):384-97. PubMed ID: 24688157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
